View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Recombinant Human Hyaluronidase 2400 / Subcutaneous Immunoglobulin-G 30, Primary Antibody Deficiency, Cycle 2+
Protocol-ID: 1731 V1.0 (Mini), RHUH2400/SCIgG30, prim. Antibody Deficiency, C2+Indication(s)
- Antibody Deficiency, Primary
Links
- prescribing information for Recombinant Human Hyaluronidase (HYQVIA) (FDA) [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 12.03.2021